Episode

Breast Cancer — 5-Minute Journal Club Issue 4 with Dr Kevin Kalinsky: Defining the Role of TROP2-Directed Antibody-Drug Conjugates

Podcast
Breast Cancer Update
Published
Oct 27, 2025
Duration seconds
940
Processing state
not_requested
Canonical source
https://breast-oncology.captivate.fm/episode/5461-5mjc2025-trop2breast-4
Audio
https://dts.podtrac.com/redirect.mp3/episodes.captivate.fm/episode/1c2d9dc0-6300-4289-8ca7-590f3815d993.mp3
JSON
/v1/public/podcasts/breast-cancer-update-757579/episodes/breast-cancer-5-minute-journal-club-issue-4-with-dr-kevin-kalinsky-defining-the-role-of-trop2-directed-antibody-drug-conjugates
Markdown
/podcast/breast-cancer-update-757579/breast-cancer-5-minute-journal-club-issue-4-with-dr-kevin-kalinsky-defining-the-role-of-trop2-directed-antibody-drug-conjugates.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/breast-cancer-update-757579/episodes/breast-cancer-5-minute-journal-club-issue-4-with-dr-kevin-kalinsky-defining-the-role-of-trop2-directed-antibody-drug-conjugates/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/breast-cancer-update-757579/breast-cancer-5-minute-journal-club-issue-4-with-dr-kevin-kalinsky-defining-the-role-of-trop2-directed-antibody-drug-conjugates.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Kevin Kalinsky from Winship Cancer Institute of Emory University in Atlanta, Georgia, discusses recent developments with TROP2-directed antibody-drug conjugates in the management of breast cancer.  CME information and select publications here .